These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31113887)

  • 1. A glycan shield on chimpanzee CD4 protects against infection by primate lentiviruses (HIV/SIV).
    Warren CJ; Meyerson NR; Stabell AC; Fattor WT; Wilkerson GK; Sawyer SL
    Proc Natl Acad Sci U S A; 2019 Jun; 116(23):11460-11469. PubMed ID: 31113887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4 receptor diversity in chimpanzees protects against SIV infection.
    Bibollet-Ruche F; Russell RM; Liu W; Stewart-Jones GBE; Sherrill-Mix S; Li Y; Learn GH; Smith AG; Gondim MVP; Plenderleith LJ; Decker JM; Easlick JL; Wetzel KS; Collman RG; Ding S; Finzi A; Ayouba A; Peeters M; Leendertz FH; van Schijndel J; Goedmakers A; Ton E; Boesch C; Kuehl H; Arandjelovic M; Dieguez P; Murai M; Colin C; Koops K; Speede S; Gonder MK; Muller MN; Sanz CM; Morgan DB; Atencia R; Cox D; Piel AK; Stewart FA; Ndjango JN; Mjungu D; Lonsdorf EV; Pusey AE; Kwong PD; Sharp PM; Shaw GM; Hahn BH
    Proc Natl Acad Sci U S A; 2019 Feb; 116(8):3229-3238. PubMed ID: 30718403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The epidemiology of simian immunodeficiency virus infection in a large number of wild- and captive-born chimpanzees: evidence for a recent introduction following chimpanzee divergence.
    Switzer WM; Parekh B; Shanmugam V; Bhullar V; Phillips S; Ely JJ; Heneine W
    AIDS Res Hum Retroviruses; 2005 May; 21(5):335-42. PubMed ID: 15929695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD4 receptor diversity represents an ancient protection mechanism against primate lentiviruses.
    Russell RM; Bibollet-Ruche F; Liu W; Sherrill-Mix S; Li Y; Connell J; Loy DE; Trimboli S; Smith AG; Avitto AN; Gondim MVP; Plenderleith LJ; Wetzel KS; Collman RG; Ayouba A; Esteban A; Peeters M; Kohler WJ; Miller RA; François-Souquiere S; Switzer WM; Hirsch VM; Marx PA; Piel AK; Stewart FA; Georgiev AV; Sommer V; Bertolani P; Hart JA; Hart TB; Shaw GM; Sharp PM; Hahn BH
    Proc Natl Acad Sci U S A; 2021 Mar; 118(13):. PubMed ID: 33771926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simian Immunodeficiency Virus Infection of Chimpanzees (Pan troglodytes) Shares Features of Both Pathogenic and Non-pathogenic Lentiviral Infections.
    Greenwood EJ; Schmidt F; Kondova I; Niphuis H; Hodara VL; Clissold L; McLay K; Guerra B; Redrobe S; Giavedoni LD; Lanford RE; Murthy KK; Rouet F; Heeney JL
    PLoS Pathog; 2015 Sep; 11(9):e1005146. PubMed ID: 26360709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.
    Etienne L; Nerrienet E; LeBreton M; Bibila GT; Foupouapouognigni Y; Rousset D; Nana A; Djoko CF; Tamoufe U; Aghokeng AF; Mpoudi-Ngole E; Delaporte E; Peeters M; Wolfe ND; Ayouba A
    Retrovirology; 2011 Jan; 8():4. PubMed ID: 21232091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.
    Barbian HJ; Decker JM; Bibollet-Ruche F; Galimidi RP; West AP; Learn GH; Parrish NF; Iyer SS; Li Y; Pace CS; Song R; Huang Y; Denny TN; Mouquet H; Martin L; Acharya P; Zhang B; Kwong PD; Mascola JR; Verrips CT; Strokappe NM; Rutten L; McCoy LE; Weiss RA; Brown CS; Jackson R; Silvestri G; Connors M; Burton DR; Shaw GM; Nussenzweig MC; Bjorkman PJ; Ho DD; Farzan M; Hahn BH
    mBio; 2015 Apr; 6(2):. PubMed ID: 25900654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage- and CD4+ T cell-derived SIV differ in glycosylation, infectivity and neutralization sensitivity.
    Karsten CB; Buettner FFR; Cajic S; Nehlmeier I; Roshani B; Klippert A; Sauermann U; Stolte-Leeb N; Reichl U; Gerardy-Schahn R; Rapp E; Stahl-Hennig C; Pöhlmann S
    PLoS Pathog; 2024 May; 20(5):e1012190. PubMed ID: 38805549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quality of chimpanzee T-cell activation and simian immunodeficiency virus/human immunodeficiency virus susceptibility achieved via antibody-mediated T-cell receptor/CD3 stimulation is a function of the anti-CD3 antibody isotype.
    Bibollet-Ruche F; McKinney BA; Duverger A; Wagner FH; Ansari AA; Kutsch O
    J Virol; 2008 Oct; 82(20):10271-8. PubMed ID: 18667496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicative fitness and pathogenicity of primate lentiviruses in lymphoid tissue, primary human and chimpanzee cells: relation to possible jumps to humans.
    Tebit DM; Nickel G; Gibson R; Rodriguez M; Hathaway NJ; Bain K; Reyes-Rodriguez AL; Ondoa P; Heeney JL; Li Y; Bongorno J; Canaday D; McDonald D; Bailey JA; Arts EJ
    EBioMedicine; 2024 Feb; 100():104965. PubMed ID: 38215691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strain of simian immunodeficiency virus identified in wild-born chimpanzees from central Africa.
    Souquière S; Makuwa M; Sallé B; Kazanji M
    PLoS One; 2012; 7(9):e44298. PubMed ID: 22984489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes.
    Gao F; Bailes E; Robertson DL; Chen Y; Rodenburg CM; Michael SF; Cummins LB; Arthur LO; Peeters M; Shaw GM; Sharp PM; Hahn BH
    Nature; 1999 Feb; 397(6718):436-41. PubMed ID: 9989410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nef proteins from simian immunodeficiency virus-infected chimpanzees interact with p21-activated kinase 2 and modulate cell surface expression of various human receptors.
    Kirchhoff F; Schindler M; Bailer N; Renkema GH; Saksela K; Knoop V; Müller-Trutwin MC; Santiago ML; Bibollet-Ruche F; Dittmar MT; Heeney JL; Hahn BH; Münch J
    J Virol; 2004 Jul; 78(13):6864-74. PubMed ID: 15194762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees.
    Heeney JL; Rutjens E; Verschoor EJ; Niphuis H; ten Haaft P; Rouse S; McClure H; Balla-Jhagjhoorsingh S; Bogers W; Salas M; Cobb K; Kestens L; Davis D; van der Groen G; Courgnaud V; Peeters M; Murthy KK
    J Virol; 2006 Jul; 80(14):7208-18. PubMed ID: 16809326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic subspecies diversity of the chimpanzee CD4 virus-receptor gene.
    Hvilsom C; Carlsen F; Siegismund HR; Corbet S; Nerrienet E; Fomsgaard A
    Genomics; 2008 Nov; 92(5):322-8. PubMed ID: 18718520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-modulation of primate lentiviral receptors by Nef proteins of simian immunodeficiency virus (SIV) of chimpanzees (SIVcpz) and related SIVs: implication for the evolutionary event at the emergence of SIVcpz.
    Nakano Y; Matsuda K; Yoshikawa R; Yamada E; Misawa N; Hirsch VM; Koyanagi Y; Sato K
    J Gen Virol; 2015 Sep; 96(9):2867-2877. PubMed ID: 26041873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area.
    Corbet S; Müller-Trutwin MC; Versmisse P; Delarue S; Ayouba A; Lewis J; Brunak S; Martin P; Brun-Vezinet F; Simon F; Barre-Sinoussi F; Mauclere P
    J Virol; 2000 Jan; 74(1):529-34. PubMed ID: 10590144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimpanzee reservoirs of pandemic and nonpandemic HIV-1.
    Keele BF; Van Heuverswyn F; Li Y; Bailes E; Takehisa J; Santiago ML; Bibollet-Ruche F; Chen Y; Wain LV; Liegeois F; Loul S; Ngole EM; Bienvenue Y; Delaporte E; Brookfield JF; Sharp PM; Shaw GM; Peeters M; Hahn BH
    Science; 2006 Jul; 313(5786):523-6. PubMed ID: 16728595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and Structure of an Antibody that Fully Neutralizes Isolate SIVmac239 Reveals Functional Similarity of SIV and HIV Glycan Shields.
    Gorman J; Mason RD; Nettey L; Cavett N; Chuang GY; Peng D; Tsybovsky Y; Verardi R; Nguyen R; Ambrozak D; Biris K; LaBranche CC; Ramesh A; Schramm CA; Zhou J; Bailer RT; Kepler TB; Montefiori DC; Shapiro L; Douek DC; Mascola JR; Roederer M; Kwong PD
    Immunity; 2019 Oct; 51(4):724-734.e4. PubMed ID: 31586542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.